The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyAlexandre Loupy, Michael Mengel, Mark Haas et al.|American Journal of Transplantation|2016Cited by 625
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic TestingÉric Thervet, Christophe Legendre, Marie‐Anne Loriot et al.|Clinical Pharmacology & Therapeutics|2010Cited by 363
A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantationMarianne Delville, Minnie Sarwal, Nada Alachkar et al.|Science Translational Medicine|2014Cited by 231
Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail InpatientsÉric Pautas, Virginie Siguret, Caroline Moreau et al.|Clinical Pharmacology & Therapeutics|2009Cited by 126
Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?Guillaume Canaud, Christophe Legendre|American Journal of Transplantation|2010Cited by 68